文章摘要
郝晓甜,周海卫.乙型肝炎病毒标志物的临床意义及研究进展[J].中国药事,2024,38(9):1086-1092
乙型肝炎病毒标志物的临床意义及研究进展
Clinical Significance and Research Progress of Hepatitis B Virus Markers
投稿时间:2024-06-11  
DOI:10.16153/j.1002-7777.20240471
中文关键词: 乙型肝炎病毒  血清学标志物  病毒学标志物  新型标志物
英文关键词: Hepatitis B Virus  serological markers  virological markers  new markers
基金项目:
作者单位
郝晓甜 中国食品药品检定研究院国家药品监督管理局医疗器械质量研究与评价重点实验室国家药品监督管理局体外诊断试剂质量研究与评价重点实验室北京 100050 
周海卫 中国食品药品检定研究院国家药品监督管理局医疗器械质量研究与评价重点实验室国家药品监督管理局体外诊断试剂质量研究与评价重点实验室北京 100050 
摘要点击次数: 22
全文下载次数: 8
中文摘要:
      乙型肝炎是由乙型肝炎病毒(Hepatitis B Virus,HBV)感染引起的一种严重危害人类健康的传染病。HBV感染呈世界性流行,造成严重的公共卫生问题。目前,随着疫苗的接种及抗病毒药物的治疗降低了HBV的感染,但HBV的消除仍是一大难题。HBV标志物是诊断HBV感染、观察疾病进展以及评估抗病毒治疗效果的最主要检测指标。临床上,HBV标志物主要包括传统血清学标志物和病毒学标志物以及新型标志物。近年来出现的新型标志物能更准确地评估HBV感染的活性和抗病毒治疗效果,对慢性乙型肝炎的治疗监测具有重要价值。本文就HBV标志物尤其是新型标志物的临床意义及研究进展进行综述, 旨在为HBV的精准诊断、治疗以及临床预后等提供参考。
英文摘要:
      Hepatitis B is a contagious disease that poses a severe threat to human health, caused by the infection of the Hepatitis B Virus (HBV). HBV infection is a prevalent worldwide, resulting in significant public health issues. Currently, with the administration of vaccines, and the treatment of antiviral drugs, the infection rate of HBV has been reduced. However, the eradication of HBV remains a major challenge. HBV markers are the primary indicators for diagnosing HBV infection, monitoring the progression of the disease, and evaluating the efficacy of antiviral treatment. Clinically, HBV markers mainly include traditional serological markers, virological markers, and new markers. In recent years, new markers have been developed which can more accurately evaluate the activity of HBV infection and the efficacy of antiviral therapy, and are of great value in monitoring the treatment of chronic hepatitis B. In this paper, the clinical significance and research progress of HBV markers, especially new markers, are reviewed, in order to provide references for accurate diagnosis, treatment and clinical prognosis of HBV.
查看全文   查看/发表评论  下载PDF阅读器
关闭